Biodesy’s technology directly and dynamically measures structural changes of biological molecules in high throughput. Our vision is to help transform our understanding of how biomolecules work, by enabling the study of all relevant interactions of dynamic, functional biomolecules.
The use of structural information in biomolecule analysis has been historically limited by cost and throughput. Existing structural techniques, such as x-ray crystallography and NMR, require significant time and resources, limiting their utility to a few primary candidates. However, SHG enables high-throughput analysis of biomolecules to gain early structural insights into biomolecular function.
BlueLight Therapeutics is a branch of Biodesy focused on leveraging our novel platform to drive drug discovery on high-value, challenging drug targets.Learn More